The independent source for health policy research, polling, and news.
1,101-1,120 of 112,920 results
As FiercePharma explains, the company is attempting to rebrand itself in the wake of a Justice Department investigation, a class-action lawsuit, and a failed attempt at treating Alzheimer’s. Plus: The FDA says Novo failed to report suspected incidents of GLP-1 side effects, as required by law.
The legislation includes $31 million to reinstate eligibility to thousands of people who lost coverage March 1 in the wake of a $120 million budget shortfall caused by federal funding cuts, WUSF reported. Separately, Missouri lawmakers have cleared the way for pregnant people to get a divorce.
The Joint Economic Committee found that last year, the average American senior’s Medicare premiums were about 10% higher, or more than $200 annually, because of the alleged overpayments. Also: a CBS News analysis of alleged fraud among hospices in Los Angeles.
The Trump administration has touted the synthetic vitamin B9 as a way to treat autism, but there is insufficient data to support the drug's use for it, an FDA official said. The new approval is for the treatment of cerebral folate deficiency.
The Washington Post, citing two people familiar with the matter who spoke on the condition of anonymity, reported that the Advisory Committee on Immunization Practices has dropped its questioning of covid shots' safety amid Republicans' fears that more changes to vaccine policy could hurt the party in the midterm elections.
Today's early morning highlights from the major news organizations.
Meanwhile, a small study has linked wildfire smoke inhalation to a decline in mental well-being. The data show that even a few days of exposure can lead to temporary bouts of depression.
The bill is sponsored by Arizona Sen. Ruben Gallego, a Democrat and Marine Corps veteran. The legislation would designate the Department of Veterans Affairs' medical facilities as “innovative therapies centers of excellence” and calls for $30 million to be appropriated each fiscal year “to support the research and education activities of the centers.”
Researchers reported Monday that thousands of Black kidney transplant candidates have moved up in priority on the waiting list. This comes as a remedy for a racially biased medical test that's no longer in use. Other industry news is on infection-related cancers after transplants, shrinking health care jobs, and more.
The CMS administrator says he thinks fraud, duplicative sign-ups, and enrollment mistakes might have contributed to "too high of a number" of participants. Plus, the Centers for Medicare & Medicaid Services is proposing to remodel the health insurance exchanges.
According to the Food and Drug Administration, biologic medicines make up about 5% of prescriptions, yet they account for 51% of drug spending. Other FDA news is on a probe into rare-disease drug denials, flavored e-cigarettes, and more.
The procedure will be allowed to protect the life of a woman. Abortion advocates plan to ask the courts to block the ban. “Regrettably, this act represents another well-intentioned but likely fragile legal effort with significant risk of ending in the courts," Republican Gov. Mark Gordon has said.
Opinion writers weigh in on these topics and others.
Today's early morning highlights from the major news organizations.
Opinion writers weigh in on these topics and others.
Researchers aren't sure what's behind the rise in insufficient sleep, but screen time doesn't seem to be the cause. Other wellness news is on a baby sleepsuit recall, the pandemic's impact on the cognitive development of young children, and more.
The North Carolina State Health Plan is rolling out to more than 700,000 teachers, state workers, and their families. The unusual approach is an effort to save the state money on health care in the long run. Plus, news from New Hampshire, Colorado, Illinois, Florida, and elsewhere.
State lawmakers had tried to prevent national chains from moving in and replacing local physicians, but nonprofit PeaceHealth tapped an Atlanta-based company to staff its Oregon emergency rooms, STAT reports. Doctors, lawmakers, and others are pushing back on that decision.
The potential partnership comes a month after Novo sued Hims over obesity drug knockoffs. Also: A new study finds that generic versions of Ozempic and Wegovy could be sold for less than $3 a month.
Industry leaders and academics are concerned that decision-making input from agency leaders, drug developers, patients, and physicians has largely been cast aside during the Trump administration. Plus, Democrats are going to drugmakers directly for information about Trump's drug deals.
© 2026 KFF